Smart Pills Market by Application (Capsule Endoscopy, Drug Delivery, Patient Monitoring), Target Area (Esophagus, Small Intestine, Large Intestine, Stomach), End User (Hospitals, Diagnostic Centers), Region - Global Forecast to 2028

Abstract
The global smart pills market is projected to reach USD 1.1 billion by 2028 from USD 0.6 billion in 2023, at a CAGR of 11.8% during the forecast period. Growth in this market is majorly driven by the rise in demand for non-invasive diagnostic monitoring devices, technological advancements in capsule endoscopy and significant advancements in capsule endoscopy technology.

The growing demand for advanced drug delivery systems and need for a rapid drug development process are expected to offer opportunities for market players during the forecast period. On the other hand, technological incompetence of smart pills in some conditions is expected to restrain the market growth to some extent in the coming years

“The vital sign monitoring segment is projected to grow at the highest CAGR during the forecast period.”

Based on application, the market for smart pills is divided into segments for target drug devliery, capsule endoscopy, and vital sign monitoring. The vital sign monitoring segments is projected to grow at the highest CAGR during the forecast period. This is due to the increasing need for precise and accurate measurement of inner body temperature and insufficient integration with digital health systems in conventional vital sign monitoring devices.

As healthcare systems strive for interoperability and comprehensive patient records, the rising need for vital sign monitoring devices that integrate smoothly with digital health systems becomes crucial. The growing demand for streamlined integration is expected to increase the adoption of smart pills due to advanced connectivity and compatibility with digital health systems.

“The large intestine target area accounted for the second largest share of the market during the forecast period. “

Based on target area, the smart pills market is broadly segmented into, small intestine, large intestine, esophagus, and stomach. The large intestine target area accounted for the second largest share in 2022 and this is attributed to the increasing cases of colorectal cancer and need for effective screening, diagnosis, and monitoring of inflammatory bowel diseases and other gastrointestinal disorders. The increasing cases of colorectal cancer have contributed to the growing adoption of smart pills in large intestine as smart pills can reach areas of the colon that may be challenging to visualize with traditional methods.

The diagnostic centers segment accounted for the second largest share of the market in 2022

Based on end users, the smart pills market is broadly segmented into diagnostic centers, hospitals, and other end users. Diagnostic centers are the second largest end users of the smart pills market. This can be attributed to the advancements in technology, demand for non-invasive diagnostics, and improved diagnostic accuracy. The integration of smart pills in diagnostic centers has been a key factor in driving utilization by offering expanded diagnostic capabilities, enhanced patient experience, improved operational efficiency, and the ability to facilitate remote diagnostics.

Europe accounted for the second largest share of the smart pills market in 2022

In 2022, Europe accounted for the second largest share of the smart pills market. This can be attributed to factors such as growth in ageing population and increased utilization of capsule endoscopy for gastrointestinal bleeding. The endorsement of capsule endoscopy by the European Society of Gastrointestinal Endoscopy (ESGE) guidelines provides a standardized approach for healthcare professionals, enhancing the quality of care provided to patients. As a result, there is a growing demand for smart pills and related technologies, driven by the increased utilization of capsule endoscopy for gastrointestinal bleeding.

The break up of the profile of primary participants in the smart pills market:
•By Company Type: Tier 1- 60%, Tier 2- 30%, and Tier 3-10%
•By Designation: C-level Executives- 50%, Directors- 40% , and Others- 10%.
•By Region: North America- 45%, Europe- 35%, Asia Pacific- 15%, and Rest of the World- 5%.

Key players in the Smart pills market
The key players operating in the smart pills market include RF Co., Ltd (Japan), etectrx(US), Olympus Corporation (Japan), BodyCap (France), Chongqing Jinshan Science Technology (Group) Co., Ltd (China), Check-Cap Ltd. (Israel), CapsoVision,Inc. (US), ANX Robotica Corp. (US), Medtronic plc (US), IntroMedic (South Korea), Shenzen Jifu Medical Technology Co., Ltd (China) and Otsuka America Pharmaceutical, Inc. (US).

Research Coverage:
The report analyzes the smart pills market and aims at estimating the market size and future growth potential of this market based on various segments such as application, target area, and end user. The report also includes a product portfolio matrix of various smart pills products available in the market. The report also provides a competitive analysis of the key players in this market, along with their company profiles, service offerings, and key market strategies.

Reasons to Buy the Report
The report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn would help them, garner a more significant share of the market. Firms purchasing the report could use one or any combination of the below-mentioned strategies to strengthen their position in the market.

This report provides insights into the following pointers:
•Market Penetration: Comprehensive information on product portfolios offered by the top players in the global smart pills market. The report analyzes this market by applications, target area and end user.
•Service Enhancement/Innovation: Detailed insights on upcoming trends in the global smart pills market
•Market Development: Comprehensive information on the lucrative emerging markets by applications, target area and end user.
•Market Diversification: Exhaustive information about new services or service enhancements, growing geographies, recent developments, and investments in the global smart pills market.
•Competitive Assessment: In-depth assessment of market shares, growth strategies, product offerings, company evaluation quadrant, and capabilities of leading players in the global smart pills market.

Content
Table of Contents

1INTRODUCTION20
1.1STUDY OBJECTIVES20
1.2MARKET DEFINITION20
1.2.1INCLUSIONS AND EXCLUSIONS21
1.3MARKET SCOPE21
1.3.1MARKETS COVERED21
FIGURE 1SMART PILLS MARKET: MARKET SEGMENTATION21
1.3.2YEARS CONSIDERED22
1.4CURRENCY CONSIDERED22
1.5LIMITATIONS22
1.6STAKEHOLDERS22
1.7SUMMARY OF CHANGES23
1.8RECESSION IMPACT23
2RESEARCH METHODOLOGY24
2.1RESEARCH APPROACH24
FIGURE 2RESEARCH DESIGN24
2.1.1SECONDARY RESEARCH24
2.1.1.1Key data from secondary sources25
2.1.2PRIMARY DATA26
FIGURE 3PRIMARY SOURCES26
2.1.2.1Key data from primary sources27
2.1.2.2Insights from primary experts27
FIGURE 4BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION28
2.1.3MARKET SIZE ESTIMATION28
FIGURE 5MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS29
FIGURE 6SMART PILLS MARKET: SEGMENTAL EXTRAPOLATION30
FIGURE 7SMART PILLS MARKET: CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES (2023–2028)31
FIGURE 8CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS31
2.2MARKET BREAKDOWN AND DATA TRIANGULATION METHODOLOGY33
FIGURE 9SMART PILLS MARKET: DATA TRIANGULATION METHODOLOGY33
2.3MARKET SHARE ANALYSIS34
2.4STUDY ASSUMPTIONS34
2.5LIMITATIONS34
2.5.1METHODOLOGY-RELATED LIMITATIONS34
 
2.6RISK ASSESSMENT35
TABLE 1SMART PILLS MARKET: RISK ASSESSMENT ANALYSIS35
2.7RECESSION IMPACT ANALYSIS35
3EXECUTIVE SUMMARY36
FIGURE 10SMART PILLS MARKET, BY APPLICATION, 2023 VS. 2028 (USD MILLION)36
FIGURE 11SMART PILLS MARKET, BY TARGET AREA, 2023 VS. 2028 (USD MILLION)37
FIGURE 12SMART PILLS MARKET, BY END USER, 2023 VS. 2028 (USD MILLION)37
FIGURE 13GEOGRAPHICAL SNAPSHOT OF SMART PILLS MARKET38
4PREMIUM INSIGHTS39
4.1SMART PILLS MARKET OVERVIEW39
FIGURE 14RISING TECHNOLOGICAL ADVANCEMENTS IN CAPSULE ENDOSCOPES TO DRIVE MARKET39
4.2NORTH AMERICA: SMART PILLS MARKET, BY END USER AND COUNTRY40
FIGURE 15HOSPITALS ACCOUNTED FOR LARGEST MARKET SHARE IN US FOR 202240
4.3SMART PILLS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES40
FIGURE 16CHINA TO GROW AT HIGHEST CAGR DURING FORECAST PERIOD40
4.4SMART PILLS MARKET: REGIONAL MIX41
FIGURE 17NORTH AMERICA TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD41
4.5SMART PILLS MARKET: DEVELOPING VS. EMERGING MARKETS41
FIGURE 18EMERGING MARKETS TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD41
5MARKET OVERVIEW42
5.1INTRODUCTION42
5.2MARKET DYNAMICS42
FIGURE 19SMART PILLS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES42
TABLE 2SMART PILLS MARKET: IMPACT ANALYSIS43
5.2.1DRIVERS43
5.2.1.1Rising demand for noninvasive diagnostic monitoring devices43
5.2.1.2Technological advancements in capsule endoscopy44
5.2.1.3Increasing incidence of colon cancer44
5.2.2RESTRAINTS45
5.2.2.1High costs45
5.2.2.2Technical limitations associated with accuracy of smart pills45
5.2.3OPPORTUNITIES46
5.2.3.1Growing demand for advanced drug delivery systems46
5.2.3.2Rising need for rapid drug delivery development46
5.2.4CHALLENGES47
5.2.4.1Patient privacy concerns47
 
5.3INDUSTRY TRENDS47
5.3.1ADVANCEMENTS IN SENSOR TECHNOLOGY47
5.3.2INTEGRATION WITH WEARABLE DEVICES48
5.4TECHNOLOGY ANALYSIS48
5.4.1SELF-POWERED INGESTIBLE SMART PILL48
5.4.2ADAPTIVE FRAME RATE TECHNOLOGY48
5.4.3IMAG (INGESTIBLE MICRODEVICES FOR ANATOMIC MAPPING OF GASTROINTESTINAL TRACT)49
TABLE 3SENSOR AND BATTERY TYPES USED FOR CAPSULE ENDOSCOPY PRODUCTS49
TABLE 4SENSOR USED FOR VITAL SIGN MONITORING AND DRUG INGESTION TRACKING PRODUCTS50
TABLE 5SMART PILLS MARKET: DRUGS UNDER PIPELINE51
5.5PORTER’S FIVE FORCES ANALYSIS52
TABLE 6PORTER’S FIVE FORCES ANALYSIS52
5.5.1THREAT OF NEW ENTRANTS52
5.5.2THREAT OF SUBSTITUTES53
5.5.3BARGAINING POWER OF SUPPLIERS53
5.5.4BARGAINING POWER OF BUYERS53
5.5.5INTENSITY OF COMPETITIVE RIVALRY53
5.6ECOSYSTEM ANALYSIS54
FIGURE 20SMART PILLS MARKET: ECOSYSTEM ANALYSIS54
5.7VALUE CHAIN ANALYSIS54
FIGURE 21SMART PILLS MARKET: VALUE CHAIN ANALYSIS55
5.8PATENT ANALYSIS55
5.8.1PATENT PUBLICATION TRENDS FOR SMART PILLS56
FIGURE 22PATENT PUBLICATION TRENDS (JANUARY 2012–DECEMBER 2022)56
5.8.2INSIGHTS: JURISDICTION AND TOP APPLICANT ANALYSIS56
FIGURE 23TOP APPLICANTS (COMPANIES/INSTITUTIONS) FOR SMART PILLS PATENTS (JANUARY 2012–DECEMBER 2022)57
FIGURE 24TOP APPLICANTS FOR SMART PILLS PATENTS (COUNTRY/REGION) (JANUARY 2012–JANUARY 2022)57
TABLE 7SMART PILLS MARKET: LIST OF PATENTS (2020–2023)58
5.9PRICING ANALYSIS60
TABLE 8PRICE RANGE FOR SMART PILLS (2022)60
5.10KEY CONFERENCES AND EVENTS60
TABLE 9SMART PILLS MARKET: DETAILED LIST OF CONFERENCES AND EVENTS (2023-2024)60
5.11REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS61
TABLE 10LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS61
5.12REGULATORY ANALYSIS62
5.12.1NORTH AMERICA62
5.12.1.1US62
TABLE 11US FDA: MEDICAL DEVICE CLASSIFICATION62
TABLE 12US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS62
5.12.2EUROPE63
5.12.3ASIA PACIFIC63
5.12.3.1Japan63
TABLE 13JAPAN: MEDICAL DEVICE CLASSIFICATION UNDER PMDA63
5.12.3.2China64
TABLE 14CHINA: CLASSIFICATION OF MEDICAL DEVICES64
5.13KEY STAKEHOLDERS AND BUYING CRITERIA65
5.13.1KEY STAKEHOLDERS IN BUYING PROCESS65
FIGURE 25INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY APPLICATION65
TABLE 15INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY APPLICATION (%)65
5.13.2BUYING CRITERIA65
FIGURE 26KEY BUYING CRITERIA FOR SMART PILLS, BY APPLICATION65
TABLE 16KEY BUYING CRITERIA FOR SMART PILLS, BY APPLICATION66
6SMART PILLS MARKET, BY TARGET AREA67
6.1INTRODUCTION68
TABLE 17SMART PILLS MARKET, BY TARGET AREA, 2021–2028 (USD MILLION)68
6.2SMALL INTESTINE68
6.2.1RISING INCIDENCE OF SMALL INTESTINE DISORDERS TO DRIVE MARKET68
TABLE 18SMART PILLS MARKET FOR SMALL INTESTINE, BY COUNTRY, 2021–2028 (USD MILLION)69
6.3LARGE INTESTINE70
6.3.1INCREASING INCIDENCE OF COLORECTAL CANCER TO SUPPORT MARKET GROWTH70
TABLE 19SMART PILLS MARKET FOR LARGE INTESTINE, BY COUNTRY, 2021–2028 (USD MILLION)71
6.4ESOPHAGUS71
6.4.1EVALUATION AND MONITORING OF BARRETT’S ESOPHAGUS TO PROPEL MARKET71
TABLE 20SMART PILLS MARKET FOR ESOPHAGUS, BY COUNTRY, 2021–2028 (USD MILLION)72
6.5STOMACH72
6.5.1IMPROVED DIAGNOSTIC ACCURACY TO SUPPORT MARKET GROWTH72
TABLE 21SMART PILLS MARKET FOR STOMACH, BY COUNTRY, 2021–2028 (USD MILLION)73
7SMART PILLS MARKET, BY APPLICATION74
7.1INTRODUCTION75
TABLE 22SMART PILLS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)75
7.2CAPSULE ENDOSCOPY75
7.2.1ABILITY TO ASSESS GASTROINTESTINAL BLEEDING AND SMALL-BOWL TUMORS TO DRIVE MARKET75
TABLE 23CAPSULE ENDOSCOPES OFFERED BY KEY MARKET PLAYERS76
TABLE 24SMART PILLS MARKET FOR CAPSULE ENDOSCOPY, BY COUNTRY, 2021–2028 (USD MILLION)77
7.3VITAL SIGN MONITORING77
7.3.1LAUNCH OF INNOVATIVE SENSOR TECHNOLOGIES TO PROPEL MARKET77
TABLE 25VITAL SIGN MONITORING SMART PILLS UNDER PIPELINE78
TABLE 26SMART PILLS MARKET FOR VITAL SIGN MONITORING, BY COUNTRY, 2021–2028 (USD MILLION)78
7.4TARGETED DRUG DELIVERY79
7.4.1SITE-SPECIFIC DRUG DELIVERY INTEGRATION WITH SMART PILLS TO SUPPORT MARKET GROWTH79
TABLE 27TARGETED DRUG DELIVERY SMART PILLS UNDER PIPELINE80
TABLE 28SMART PILLS MARKET FOR TARGETED DRUG DELIVERY, BY COUNTRY, 2021–2028 (USD MILLION)80
8SMART PILLS MARKET, BY END USER81
8.1INTRODUCTION82
TABLE 29SMART PILLS MARKET, BY END USER, 2021–2028 (USD MILLION)82
8.2HOSPITALS82
8.2.1RISING NEED FOR TECHNOLOGICALLY ADVANCED ENDOSCOPY PROCEDURES TO DRIVE MARKET82
TABLE 30SMART PILLS MARKET FOR HOSPITALS, BY COUNTRY, 2021–2028 (USD MILLION)83
8.3DIAGNOSTIC CENTERS83
8.3.1GROWING PREFERENCE FOR NONINVASIVE DIAGNOSTICS TO PROPEL MARKET83
TABLE 31SMART PILLS MARKET FOR DIAGNOSTIC CENTERS, BY COUNTRY, 2021–2028 (USD MILLION)84
8.4OTHER END USERS84
TABLE 32SMART PILLS MARKET FOR OTHER END USERS, BY COUNTRY, 2021–2028 (USD MILLION)85
9SMART PILLS MARKET, BY REGION86
9.1INTRODUCTION87
TABLE 33SMART PILLS MARKET, BY REGION, 2021–2028 (USD MILLION)87
TABLE 34CAPSULE ENDOSCOPY MARKET, BY REGION, 2021–2028 (MILLION UNITS)87
TABLE 35VITAL SIGN MONITORING MARKET, BY REGION, 2021–2028 (MILLION UNITS)88
9.2NORTH AMERICA88
FIGURE 27NORTH AMERICA: SMART PILLS MARKET SNAPSHOT89
TABLE 36NORTH AMERICA: SMART PILLS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)89
TABLE 37NORTH AMERICA: SMART PILLS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)90
TABLE 38NORTH AMERICA: SMART PILLS MARKET, BY TARGET AREA, 2021–2028 (USD MILLION)90
TABLE 39NORTH AMERICA: SMART PILLS MARKET, BY END USER, 2021–2028 (USD MILLION)90
9.2.1US91
9.2.1.1Favorable reimbursements for endoscopy procedures to drive market91
TABLE 40US: SMART PILLS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)92
TABLE 41US: SMART PILLS MARKET, BY TARGET AREA, 2021–2028 (USD MILLION)92
TABLE 42US: SMART PILLS MARKET, BY END USER, 2021–2028 (USD MILLION)92
9.2.2CANADA93
9.2.2.1Rising incidence of IBD to drive market93
TABLE 43CANADA: SMART PILLS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)93
TABLE 44CANADA: SMART PILLS MARKET, BY TARGET AREA, 2021–2028 (USD MILLION)93
TABLE 45CANADA: SMART PILLS MARKET, BY END USER, 2021–2028 (USD MILLION)94
9.2.3NORTH AMERICA: RECESSION IMPACT94
9.3EUROPE94
TABLE 46EUROPE: SMART PILLS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)95
TABLE 47EUROPE: SMART PILLS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)95
TABLE 48EUROPE: SMART PILLS MARKET, BY TARGET AREA, 2021–2028 (USD MILLION)95
TABLE 49EUROPE: SMART PILLS MARKET, BY END USER, 2021–2028 (USD MILLION)96
9.3.1GERMANY96
9.3.1.1Rising incidence of Chron’s disease to drive market96
TABLE 50GERMANY: SMART PILLS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)97
TABLE 51GERMANY: SMART PILLS MARKET, BY TARGET AREA, 2021–2028 (USD MILLION)97
TABLE 52GERMANY: SMART PILLS MARKET, BY END USER, 2021–2028 (USD MILLION)97
9.3.2UK98
9.3.2.1Utilization of capsule endoscopy for bowel cancer to drive market98
TABLE 53UK: SMART PILLS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)98
TABLE 54UK: SMART PILLS MARKET, BY TARGET AREA, 2021–2028 (USD MILLION)99
TABLE 55UK: SMART PILLS MARKET, BY END USER, 2021–2028 (USD MILLION)99
9.3.3FRANCE99
9.3.3.1Reimbursement coverage for small bowel capsule endoscopy to drive market99
TABLE 56FRANCE: SMART PILLS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)100
TABLE 57FRANCE: SMART PILLS MARKET, BY TARGET AREA, 2021–2028 (USD MILLION)100
TABLE 58FRANCE: SMART PILLS MARKET, BY END USER, 2021–2028 (USD MILLION)100
9.3.4ITALY101
9.3.4.1Rising adoption of technologically advanced endoscopes to support market growth101
TABLE 59ITALY: SMART PILLS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)101
TABLE 60ITALY: SMART PILLS MARKET, BY TARGET AREA, 2021–2028 (USD MILLION)101
TABLE 61ITALY: SMART PILLS MARKET, BY END USER, 2021–2028 (USD MILLION)102
9.3.5REST OF EUROPE102
TABLE 62REST OF EUROPE: SMART PILLS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)102
TABLE 63REST OF EUROPE: SMART PILLS MARKET, BY TARGET AREA, 2021–2028 (USD MILLION)103
TABLE 64REST OF EUROPE: SMART PILLS MARKET, BY END USER, 2021–2028 (USD MILLION)103
9.3.6EUROPE: RECESSION IMPACT103
9.4ASIA PACIFIC104
FIGURE 28ASIA PACIFIC: SMART PILLS MARKET SNAPSHOT104
TABLE 65ASIA PACIFIC: SMART PILLS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)105
TABLE 66ASIA PACIFIC: SMART PILLS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)105
TABLE 67ASIA PACIFIC: SMART PILLS MARKET, BY TARGET AREA, 2021–2028 (USD MILLION)105
TABLE 68ASIA PACIFIC: SMART PILLS MARKET, BY END USER, 2021–2028 (USD MILLION)106
9.4.1JAPAN106
9.4.1.1Rising incidence of gastric cancer to drive market106
TABLE 69JAPAN: SMART PILLS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)107
TABLE 70JAPAN: SMART PILLS MARKET, BY TARGET AREA, 2021–2028 (USD MILLION)107
TABLE 71JAPAN: SMART PILLS MARKET, BY END USER, 2021–2028 (USD MILLION)107
9.4.2CHINA108
9.4.2.1Increasing funding initiatives for development of smart pills to fuel market108
TABLE 72CHINA: SMART PILLS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)108
TABLE 73CHINA: SMART PILLS MARKET, BY TARGET AREA, 2021–2028 (USD MILLION)109
TABLE 74CHINA: SMART PILLS MARKET, BY END USER, 2021–2028 (USD MILLION)109
9.4.3INDIA109
9.4.3.1Rising incidence of IBD to support market growth109
TABLE 75INDIA: SMART PILLS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)110
TABLE 76INDIA: SMART PILLS MARKET, BY TARGET AREA, 2021–2028 (USD MILLION)110
TABLE 77INDIA: SMART PILLS MARKET, BY END USER, 2021–2028 (USD MILLION)110
9.4.4REST OF ASIA PACIFIC111
TABLE 78REST OF ASIA PACIFIC: SMART PILLS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)111
TABLE 79REST OF ASIA PACIFIC: SMART PILLS MARKET, BY TARGET AREA, 2021–2028 (USD MILLION)111
TABLE 80REST OF ASIA PACIFIC: SMART PILLS MARKET, BY END USER, 2021–2028 (USD MILLION)112
9.4.5ASIA PACIFIC: RECESSION IMPACT112
 
9.5REST OF THE WORLD112
TABLE 81REST OF THE WORLD: SMART PILLS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)113
TABLE 82REST OF THE WORLD: SMART PILLS MARKET, BY TARGET AREA, 2021–2028 (USD MILLION)113
TABLE 83REST OF THE WORLD: SMART PILLS MARKET, BY END USER, 2021–2028 (USD MILLION)113
10COMPETITIVE LANDSCAPE114
10.1OVERVIEW114
10.2STRATEGIES ADOPTED BY KEY PLAYERS114
TABLE 84OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS115
10.2.1REVENUE SHARE ANALYSIS116
FIGURE 29REVENUE SHARE ANALYSIS OF LEADING PLAYERS116
10.2.2MARKET SHARE ANALYSIS117
FIGURE 30SMART PILLS MARKET SHARE, BY KEY PLAYER (2022)117
10.3COMPANY EVALUATION QUADRANT FOR KEY PLAYERS118
10.3.1STARS118
10.3.2EMERGING LEADERS118
10.3.3PERVASIVE PLAYERS118
10.3.4PARTICIPANTS118
FIGURE 31SMART PILLS MARKET: COMPANY EVALUATION MATRIX FOR KEY PLAYERS (2022)119
10.4COMPANY FOOTPRINT ANALYSIS119
TABLE 85SMART PILLS MARKET: COMPANY FOOTPRINT ANALYSIS120
10.4.1APPLICATION FOOTPRINT ANALYSIS121
TABLE 86SMART PILLS MARKET: APPLICATION FOOTPRINT121
10.4.2TARGET AREA FOOTPRINT ANALYSIS122
TABLE 87SMART PILLS MARKET: TARGET AREA FOOTPRINT122
10.4.3END USER FOOTPRINT ANALYSIS123
TABLE 88SMART PILLS MARKET: END USER FOOTPRINT123
10.4.4REGIONAL FOOTPRINT ANALYSIS124
TABLE 89SMART PILLS MARKET: REGIONAL FOOTPRINT124
10.5COMPETITIVE SCENARIO125
10.5.1PRODUCT LAUNCHES & APPROVALS125
TABLE 90SMART PILLS MARKET: PRODUCT LAUNCHES & APPROVALS (JANUARY 2020–JUNE 2023)125
10.5.2DEALS126
TABLE 91SMART PILLS MARKET: DEALS (JANUARY 2020–JUNE 2023)126
10.5.3OTHER DEVELOPMENTS127
TABLE 92SMART PILLS MARKET: OTHER DEVELOPMENTS (JANUARY 2020–JUNE 2023)127
 
11COMPANY PROFILES128
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
11.1KEY PLAYERS128
11.1.1OLYMPUS CORPORATION128
TABLE 93OLYMPUS CORPORATION: BUSINESS OVERVIEW128
FIGURE 32OLYMPUS CORPORATION: COMPANY SNAPSHOT (2022)129
11.1.2CAPSOVISION, INC.131
TABLE 94CAPSOVISION, INC.: BUSINESS OVERVIEW131
11.1.3MEDTRONIC PLC133
TABLE 95MEDTRONIC PLC: BUSINESS OVERVIEW133
FIGURE 33MEDTRONIC PLC: COMPANY SNAPSHOT (2022)134
11.1.4INTROMEDIC136
TABLE 96INTROMEDIC: BUSINESS OVERVIEW136
11.1.5ANX ROBOTICA CORP.137
TABLE 97ANX ROBOTICA CORP.: BUSINESS OVERVIEW137
11.1.6SHENZHEN JIFU MEDICAL TECHNOLOGY CO., LTD.139
TABLE 98SHENZHEN JIFU MEDICAL TECHNOLOGY CO., LTD.: BUSINESS OVERVIEW139
11.1.7CHONGQING JINSHAN SCIENCE & TECHNOLOGY (GROUP) CO., LTD.140
TABLE 99CHONGQING JINSHAN SCIENCE & TECHNOLOGY (GROUP) CO., LTD.: BUSINESS OVERVIEW140
11.1.8RF CO., LTD.141
TABLE 100RF CO., LTD.: BUSINESS OVERVIEW141
11.1.9ETECTRX142
TABLE 101ETECTRX: BUSINESS OVERVIEW142
11.1.10BODYCAP143
TABLE 102BODYCAP: BUSINESS OVERVIEW143
11.1.11OTSUKA AMERICA PHARMACEUTICAL, INC.144
TABLE 103OTSUKA AMERICA PHARMACEUTICAL, INC.: BUSINESS OVERVIEW144
11.1.12CHECK-CAP LTD.145
TABLE 104CHECK-CAP LTD.: BUSINESS OVERVIEW145
*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.
12APPENDIX147
12.1DISCUSSION GUIDE147
12.2KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL150
12.3CUSTOMIZATION OPTIONS152
12.4RELATED REPORTS152
12.5AUTHOR DETAILS153